HomeSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Nakaraang pagsara
kr 285.20
Sakop ng araw
kr 280.20 - kr 286.40
Sakop ng taon
kr 241.80 - kr 354.40
Market cap
101.60B SEK
Average na Volume
328.85K
P/E ratio
25.00
Dividend yield
-
Primary exchange
STO
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.46B | 3.34% |
Gastos sa pagpapatakbo | 3.52B | 7.71% |
Net na kita | 875.00M | 9.38% |
Net profit margin | 13.53 | 5.79% |
Kita sa bawat share | 2.72 | 1.87% |
EBITDA | 2.39B | 0.42% |
Aktuwal na % ng binabayarang buwis | 20.16% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 997.00M | 89.18% |
Kabuuang asset | 70.12B | -5.90% |
Kabuuang sagutin | 31.08B | -19.51% |
Kabuuang equity | 39.04B | — |
Natitirang share | 343.46M | — |
Presyo para makapag-book | 2.51 | — |
Return on assets | 4.98% | — |
Return on capital | 6.58% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 875.00M | 9.38% |
Cash mula sa mga operasyon | 2.30B | 1.73% |
Cash mula sa pag-invest | -94.00M | 87.38% |
Cash mula sa financing | -2.29B | -22.95% |
Net change in cash | -143.00M | 62.07% |
Malayang cash flow | 2.38B | 2,297.81% |
Tungkol
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Itinatag
1939
Website
Mga Empleyado
1,895
